EUVIMEDEUVIMED entdecken
Crossref

The efficacy of direct-acting antiviral therapy in patients with chronic hepatitis C

Irina RUSU, Liliana HODOROGEA, Tiberiu HOLBAN

One Health & Risk Management · 2020

DOI: 10.38045/ohrm.2020.1.02 ↗

Kurz gefasst

Fachartikel in der Zeitschrift One Health & Risk Management, 2020. Verfasst von Irina RUSU und 2 weiteren Autor:innen.

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Kein Abstract verfügbar.

Zitieren

APA

RUSU, I., HODOROGEA, L., & HOLBAN, T. (2020). The efficacy of direct-acting antiviral therapy in patients with chronic hepatitis C. One Health & Risk Management. https://doi.org/10.38045/ohrm.2020.1.02

Vancouver

RUSU I, HODOROGEA L, HOLBAN T. The efficacy of direct-acting antiviral therapy in patients with chronic hepatitis C. One Health & Risk Management. 2020. doi:10.38045/ohrm.2020.1.02

BibTeX
@article{RUSU2020,
  author = {RUSU, Irina and HODOROGEA, Liliana and HOLBAN, Tiberiu},
  title = {The efficacy of direct-acting antiviral therapy in patients with chronic hepatitis C},
  journal = {One Health & Risk Management},
  year = {2020},
  doi = {10.38045/ohrm.2020.1.02}
}
Kostenlos starten →